You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Citation Tools

Article menu

This article has a correction. Please see:

Original research
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bath PM, Mhlanga I, Woodhouse LJ LACI-2 Trial Investigators, et al
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
Stroke and Vascular Neurology 2023;8:doi: 10.1136/svn-2022-001816